CASI Pharmaceuticals, Inc. (CASI)

CASI Pharmaceuticals Statistics

Total Valuation

CASI has a market cap or net worth of $36.41 million. The enterprise value is $47.30 million.

Market Cap	36.41M
Enterprise Value	47.30M

Important Dates

The last earnings date was Friday, August 29, 2025, after market close.

Earnings Date	Aug 29, 2025
Ex-Dividend Date	n/a

Share Statistics

CASI has 15.49 million shares outstanding. The number of shares has increased by 21.99% in one year.

Current Share Class	15.49M
Shares Outstanding	15.49M
Shares Change (YoY)	+21.99%
Shares Change (QoQ)	+0.09%
Owned by Insiders (%)	14.41%
Owned by Institutions (%)	5.68%
Float	5.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.18
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.50
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.48

Current Ratio	0.48
Quick Ratio	0.32
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-44.50

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-62.73%
Return on Invested Capital (ROIC)	-186.63%
Return on Capital Employed (ROCE)	633.31%
Revenue Per Employee	$135,468
Profits Per Employee	-$201,245
Employee Count	233
Asset Turnover	0.77
Inventory Turnover	2.07

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -65.17% in the last 52 weeks. The beta is 0.72, so CASI's price volatility has been lower than the market average.

Beta (5Y)	0.72
52-Week Price Change	-65.17%
50-Day Moving Average	1.72
200-Day Moving Average	2.28
Relative Strength Index (RSI)	58.96
Average Volume (20 Days)	420,773

Short Selling Information

The latest short interest is 303,483, so 1.96% of the outstanding shares have been sold short.

Short Interest	303,483
Short Previous Month	28,540
Short % of Shares Out	1.96%
Short % of Float	5.08%
Short Ratio (days to cover)	0.10

Income Statement

In the last 12 months, CASI had revenue of $31.56 million and -$46.89 million in losses. Loss per share was -$2.87.

Revenue	31.56M
Gross Profit	12.95M
Operating Income	-41.39M
Pretax Income	-27.02M
Net Income	-46.89M
EBITDA	-39.76M
EBIT	-41.39M
Loss Per Share	-$2.87

Balance Sheet

The company has $6.76 million in cash and $18.73 million in debt, giving a net cash position of -$11.97 million or -$0.77 per share.

Cash & Cash Equivalents	6.76M
Total Debt	18.73M
Net Cash	-11.97M
Net Cash Per Share	-$0.77
Equity (Book Value)	-20.31M
Book Value Per Share	-1.31
Working Capital	-19.58M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 41.03%, with operating and profit margins of -131.12% and -148.56%.

Gross Margin	41.03%
Operating Margin	-131.12%
Pretax Margin	-148.56%
Profit Margin	-148.56%
EBITDA Margin	-125.97%
EBIT Margin	-131.12%
FCF Margin	n/a

Dividends & Yields

CASI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.99%
Shareholder Yield	-21.99%
Earnings Yield	-132.75%
FCF Yield	n/a

Analyst Forecast

The average price target for CASI is $4.00, which is 70.21% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.00
Price Target Difference	70.21%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	-10.84%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 2, 2022. It was a reverse split with a ratio of 1:10.

Last Split Date	Jun 2, 2022
Split Type	Reverse
Split Ratio	1:10

Scores

CASI has an Altman Z-Score of -35.94 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-35.94
Piotroski F-Score	1